BOUCHERVILLE, Quebec, June 27, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB) (the "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, announced that it ...
Acquisition is accretive, expected to boost revenues by approximately 40% and adds development and manufacturing capabilities of liquid and semi-solid products for the pharmaceutical and cosmetic ...
Adjusted Gross Margin, EBITDA, and Adjusted EBITDA are non-IFRS measures and do not have any standardized meaning under IFRS. As a result, the information presented may not be comparable to similar ...
BOUCHERVILLE, Quebec, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Groupe LSL Pharma Inc. (TSXV: LSL) – (“the Company” or “LSL Pharma Group”), a Canadian integrated ...
The Corporation delivered record quarterly revenues in Q3-25 for the fourth consecutive quarter at $7.6M, up 89% compared to Q3-24. The increase results mainly from to the addition of revenues from ...
BOUCHERVILLE, Québec, May 06, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) ("the Company" or "LSL Pharma"), a Canadian integrated pharmaceutical company, is pleased to announce that it ...
BOUCHERVILLE, QC, Nov. 25, 2024 /CNW/ - LSL PHARMA GROUP INC. (TSXV: LSL) (the " Corporation" or " LSL Pharma "), a Canadian integrated pharmaceutical company, today reported its financial and ...
BOUCHERVILLE, QC, Feb. 3, 2026 /CNW/ - LSL PHARMA GROUP INC. (TSXV: LSL) (The "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, announced today that it has granted an ...
The $2.5 million purchase price will be funded by the proceeds from the recently completed private placements. BOUCHERVILLE — LSL Pharma Group INC. has announced that it has entered into a binding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results